*By Chloe Aiello* Canopy Growth CEO Bruce Linton won't guarantee investors dividends. What he will promise is a stake in global cannabis domination. "If people want a dividend, we are probably not the right stock. If they want some entity aimed at dominating a global opportunity that started in Canada, we are probably your best bet," Linton told Cheddar on Friday, one day after the company reported a massive spike in third-quarter revenue. Beverages ー and other non-flower products ー are shaping up to be a major focus for Canopy as Canada gears up for [its second wave of cannabis legalization](https://cheddar.com/media/cheddars-crystal-ball-the-2019-outlook-for-cannabis-and-hemp), which will open the door for cannabis-infused goods like vapes, edibles and beverages by mid-October 2019. "The biggest opportunity is to be planning a year from now not to be selling very much dried cannabis flower, compared to today," Linton said. That applies both to medical cannabis, which can be sold as an insurable product, and higher-margin recreational goods, like edibles, which can sell for higher prices even with smaller quantities of cannabis. "I think the margin growth could be faster and bigger because when you sell dried cannabis you are selling it at the least advanced state," Linton said. "I think you are going to see margin opportunities just keep going up as real products are created and put into markets of both medical and \[recreational\]." Canopy Growth ($CGC) reported [third-quarter earnings](https://www.canopygrowth.com/wp-content/uploads/2019/02/Canopy-Growth-Reports-Third-Quarter-Fiscal-Year-2019-Financial-Results-1.pdf) late Thursday evening. The massive marijuana producer grew its revenue an astounding 282 percent year-over-year, but missed analyst estimates on earnings, reporting a C$0.38 loss. The company also announced that Chief Financial Officer Tim Saunders will leave the company this year. Shares were surging 4 percent on Friday. Linton said he expects Canopy will be profitable at least in Canada by the end of the year, as the company begins to make use of investments it has made in extraction and production. "What we've done is made really significant, thoughtful investments, all of which are near the finish line of being eligible to produce the cannabis, create the extraction platform, and make things like beverages," he said. For full interview [click here](https://cheddar.com/videos/canopy-growth-ceo-talks-earnings).

Share:
More In Business
Poll: More Americans think companies benefit from legal immigration
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Tylenol maker rebounds a day after unfounded claims about its safety
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
Load More